NCT07114042

Brief Summary

Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2025

Completed
10 days until next milestone

Study Start

First participant enrolled

August 8, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 11, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2026

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

August 11, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

July 29, 2025

Last Update Submit

August 8, 2025

Conditions

Upper Gastrointestinal Bleeding

Outcome Measures

Primary Outcomes (2)

  • "Mortality"

    6 months

  • Incidence of "Re_bleeding"

    6 months

Interventions

Upper endoscopyDIAGNOSTIC_TEST

Prediction of upper gastrointestinal r\_bleeding and mortality

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with upper gastrointestinal bleeding

You may qualify if:

  • Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.

You may not qualify if:

  • Incomplete clinical data.
  • Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).
  • Pregnancy
  • Patients with missing data on clinical outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine -Sohag university

Sohag, 093, Egypt

Location

MeSH Terms

Conditions

Gastrointestinal Hemorrhage

Interventions

Gastroscopy

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Reham R Baeoumy, Master

    Sohag

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reham R Baeoumy, Master

CONTACT

0106 3367488reham.refaat@med.edu.eg

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 11, 2025

Study Start

August 8, 2025

Primary Completion

January 20, 2026

Study Completion

February 1, 2026

Last Updated

August 11, 2025

Record last verified: 2025-08

Locations

EG(1)